CD8A and COVID-19: Protective B7/N105+CD8+ T cell responses in mild COVID-19 patients displayed higher functional avidity as well as optimal effector and antiviral CD8+ T cell functions, in contrast to suboptimal CD8+ T cell responses in severely ill patients.